This review summarizes the clinical background and current state of advanced imaging modalities like cardiac MR and 18F-FDG PET for the detection and management of cardiac sarcoidosis.
Answers are grounded in this paper and cite their sources.
May inform imaging selection in cardiac sarcoidosis; leaves open prospective outcome validation.
Sarcoidosis is a systemic granulomatous disease of unknown etiology. Cardiac involvement may occur, leading to an adverse outcome. Although early treatment to improve morbidity and mortality is desirable, sensitive and accurate detection of cardiac sarcoidosis remains a challenge. Accordingly, interest in the use of advanced imaging such as cardiac MR and PET with (18)F-FDG is increasing in order to refine the clinical workup. Although the field is still facing challenges and uncertainties, this article presents a summary of clinical background and the current state of diagnostic modalities and treatment of cardiac sarcoidosis.
No takes yet. Share an insight, caveat, or question.
Schatka et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: